Compare Sunrun Inc (RUN) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs Zoetis Inc — how do they compare? Sunrun Inc trades at $7.64 (market cap $1.83B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 16.5× Sunrun Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sunrun Inc for 16 Days and Zoetis Inc for 70 Days on average.
| RUN | ZTS | |
|---|---|---|
Market Cap | $1.83B | $30.20B |
Volume | 8,672,852 | 6,175,327 |
Sector | Energy | Health |
52-Week High | $21.41 | $147.53 |
52-Week Low | $7.59 | $69.09 |
Typical Hold Time | 16 Days | 70 Days |
Enterprise Value | $16.35B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sunrun (RUN) trades at $7.59, down 0.26% with a bearish technical signal despite beating earnings expectations in recent quarters. The stock shows attractive valuation metrics with P/E of 5.16 and P/S of 0.59, while maintaining positive net income margins. Recent developments include a record 580 MW grid dispatch partnership with Tesla and expanded edge computing collaboration with SPAN, though the solar sector faces headwinds from high borrowing costs impacting project financing.
The investment case balances deep value fundamentals against sector-specific challenges. While analyst consensus remains strongly bullish with a $16.33 price target representing 115% upside, investors face risks from weak cash flow generation, high debt levels, and solar industry volatility. The stock's current discount to intrinsic value presents opportunity, but requires careful monitoring of operational improvements and financing conditions.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
